B-lymphocyte hemostasis and anti-B-cell therapy areas for rheumatoid arthritis

B-lymphocyte hemostasis and anti-B-cell therapy areas for rheumatoid arthritis

Saved in:

Bibliographic Details
Main Authors:	Ekaterina Valeryevna Suponitskaya, E N Aleksandrova, A P Aleksankin, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2013-11-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1157
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IMPACT OF THERAPY WITH BIOLOGICAL AGENTS ON B-LYMPHOCYTE SUBPOPULATIONS IN RHEUMATIC DISEASES: NEW EVIDENCE
by: E. V. Suponitskaya, et al.
Published: (2015-03-01)

B-lymphocyte subpopulations in patients with rheumatoid arthritis and the effect of an interleukin-6 receptor inhibitor on them.
by: E. V. Gerasimova, et al.
Published: (2019-01-01)

T- and B-lymphocytes subpopulations in the early and advanced rheumatoid arthritis
by: A. V. Martynova, et al.
Published: (2021-04-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2012-02-01)

THE TIME COURSE OF CHANGES IN B LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING THERAPY WITH BIOLOGICAL AGENTS
by: A. A. Mesnyankina, et al.
Published: (2017-07-01)

Dynamics of T- and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs
by: A. V. Martynova, et al.
Published: (2022-02-01)

Expression of interferon-stimulated genes in patients with rheumatoid arthritis on anti-B-cell therapy (preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-10-01)

The role of monitoring the level of matrix metalloproteinase 3 in patients with rheumatoid arthritis on anti-B-cell therapy
by: A. S. Avdeeva, et al.
Published: (2022-09-01)

Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2019-03-01)

A new direction in the treatment of rheumatoid arthritis: anti-B cell therapy
by: G V Lukina, et al.
Published: (2009-02-01)

Rheumatoid arthritis: some components of hemostasis and inflammation
by: F. A. Cheldieva, et al.
Published: (2019-09-01)

T-REGULATORY CELLS IN RHEUMATOID ARTHRITIS
by: E. L. Nasonov, et al.
Published: (2014-09-01)

A Functional Polymorphism in B and T Lymphocyte Attenuator Is Associated with Susceptibility to Rheumatoid Arthritis
by: Mie Oki, et al.
Published: (2011-01-01)

PROSPECTS FOR ANTI-B-CELL THERAPY IN RHEUMATOLOGY
by: E. L. Nasonov
Published: (2018-11-01)

Low doses glucocorticoid effect on joint destruction and mineral bone density in early rheumatoid arthritis
by: E V Suponitskaya
Published: (2003-08-01)

FEATURES OF THE PHENOTYPE OF REGULATORY T CELLS IN EARLY AND ADVANCED RHEUMATOID ARTHRITIS
by: A. S. Avdeeva, et al.
Published: (2018-09-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

Functional outcomes of rheumatoid arthritis during various proceduresof anti-inflammatory therapy
by: Natalya Vladimirovna Chichasova, et al.
Published: (2010-04-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

Prospects of anti-B-cell therapy for systemic sclerosis
by: E. L. Nasonov, et al.
Published: (2025-07-01)

Role of cytokines in the pathogenesis of rheumatoid arthritis
by: Aleksandr Aleksandrovich Novikov, et al.
Published: (2010-04-01)

Current methods for laboratory diagnosis of rheumatoid arthritis
by: A A Novikov, et al.
Published: (2010-02-01)

CHANGES IN THE LEVEL OF FoxP3+ REGULATORY T LYMPHOCYTES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING METHOTREXATE THERAPY
by: A. S. Avdeeva, et al.
Published: (2017-09-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

RITUXIMAB THERAPY MONITORING IN PATIENTS WITH RHEUMATOID ARTHRITIS HROUGH PERIPHERAL BLOOD GENE EXPRESSION ANALYSIS
by: E. V. Chetina, et al.
Published: (2014-06-01)

RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01)

IMPACT OF BIOLOGICAL THERAPY ON BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: P. S. Dydykina, et al.
Published: (2014-12-01)

ANTI-B-CELL THERAPY AT IMMUNE INFLAMMATORY RHEUMATIC DISEASES: EFFICACY AND TOLERABILITY IN 229 PATIENTS
by: L. P. Ananieva, et al.
Published: (2014-10-01)

The role of the metabolic status of lymphocytes in the pathogenesis of rheumatoid arthritis
by: S. V. Skupnevsky, et al.
Published: (2021-10-01)

Anti-B cell therapy in patients with systemic lupus erythematosus
by: M. E. Tsanyan, et al.
Published: (2018-01-01)

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
by: E. V. Suponitskya, et al.
Published: (2014-10-01)

Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.
by: Diana G Adlowitz, et al.
Published: (2015-01-01)

Neutropenia in rheumatoid arthritis and large granular lymphocyte leucosis
by: V A Doronin, et al.
Published: (2003-02-01)

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01)

EFFICACY OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS IN RELATION TO ITS SERUM LEVEL AND THE PRESENCE OF ANTI-DRUG ANTIBODY
by: A. S. Avdeeva, et al.
Published: (2014-12-01)

Metabolic syndrome in rheumatoid arthritis
by: Lybov Valeryevna Kondratyeva, et al.
Published: (2013-06-01)

Dynamics of lymphocyte subpopulations, CD4+CD25+CD127- T regulatory cells in patients with rheumatoid arthritis during therapy with the rituximab biosimilar Acellbia
by: A. S. Avdeeva, et al.
Published: (2020-05-01)

Value of ultrasound indices for the assessment of rheumatoid arthritis activity and tocilizumab therapy efficiency
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-11-01)

ANTI-HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1 (ANTI-RA33) ANTIBODIES IN RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS
by: P. A. Kuznetsova, et al.
Published: (2017-04-01)

CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY)
by: A. S. Avdeeva, et al.
Published: (2014-06-01)